This is a large‐scale GWAS and MR study linking breast cancer to an increased risk of meningiomas and finding that breast cancer, especially HER‐2 positive breast cancer, raises the risk of meningiomas, which suggests genetic causation and has important clinical implications for the prevention and treatment of meningiomas. The gene discussed is ERBB2; the disease is breast cancer.